Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside
- PMID: 29346202
- PMCID: PMC5774976
- DOI: 10.1213/ANE.0000000000002690
Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside
Conflict of interest statement
None - QJQ
None - JHL
Figures
Comment on
-
Tranexamic Acid Does Not Influence Cardioprotection by Ischemic Preconditioning and Remote Ischemic Preconditioning.Anesth Analg. 2018 Feb;126(2):439-442. doi: 10.1213/ANE.0000000000002230. Anesth Analg. 2018. PMID: 28678070
References
-
- Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nature reviews Cardiology. 2016;13:193–209. - PubMed
-
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–36. - PubMed
-
- Riess ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? American journal of physiology Heart and circulatory physiology. 2004;286:H1603–7. - PubMed
-
- Fradorf J, Huhn R, Weber NC, et al. Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo. Anesthesiology. 2010;113:1289–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
